Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|June 1, 2004
Supplements and Featured Publications
- Tabloid - Future Goals, Targets, and Treatments of Dyslipidemia
- Volume 10
- Issue 1 Treat
CME/CE Quiz
Advertisement
Articles in this issue
about 22 years ago
Blocking intestinal cholesterol absorption for optimal lipid loweringabout 22 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsabout 22 years ago
Future Goals, Targets, and Treatments of Dyslipidemiaabout 22 years ago
Managed Care Commentary:MCOs face new challengesabout 22 years ago
Dual inhibition effective and safe in clinical practice: The EASE studyabout 22 years ago
Phytosterols may play role in atherosclerosisAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Student Mental Health, Success Tied to Future Health and Affordability
5